Загрузка...
Ustekinumab in Crohn’s disease: evidence to date and place in therapy
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) with uncertain etiology. Biologic agents have revolutionized the treatment of CD but nonresponders remain a challenge. Ustekinumab is an interleukin 12/23p40 inhibitor that was recently found effective in treating CD. We reviewed the curren...
Сохранить в:
| Опубликовано в: : | Ther Adv Chronic Dis |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4935835/ https://ncbi.nlm.nih.gov/pubmed/27433311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316653306 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|